DavosPharma
Upper Saddle River, NJ, United Statesdavos.comFrom their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
DavosPharma coordinates drug development outsourcing for biotech and pharmaceutical companies, with support across discovery, CMC, toxicology, and regulatory strategy. It works with a global network of vetted CROs, CDMOs, and consultants to help clients reach IND submission.
Services
Integrated IND Platform
Manages a coordinated program from CMC and toxicology through regulatory strategy and vendor coordination for IND submission.
Discovery
Coordinates hit-to-lead chemistry, ADME/PK, early biology, in vitro and in vivo pharmacology, and bioanalytical method development through vetted CROs.
Small Molecule
Matches projects involving peptides, HPAPIs, controlled substances, and complex chemistries with CDMOs for process development, scale-up, and manufacturing.
Biologics
Matches biologics programs with CDMOs for analytical development, potency testing, validation, and manufacturing of modalities such as antibodies, gene therapies, RNA-based platforms, vaccines, enzymes, and biosimilars.
Drug Product
Coordinates formulation development, preformulation assessment, tech transfer, validation support, and GMP manufacturing for drug products from capsules to injectables.
Toxicology
Coordinates GLP-compliant toxicology studies, including acute, subchronic, chronic, reproductive and DART, safety pharmacology, and genotoxicity work.
ADME, DMPK & toxicology
- Turnaround
- 3x faster average CRO onboarding time
- 10-12 months average time from lab scale familiarization to delivery of Phase 1 API
- 3x faster average CRO onboarding time compared to teams managing vendor outreach alone
- 10-12 months our average time from lab scale familiarization to delivery of Phase 1 API
Capabilities
- Assays and studies
- Small molecules
- Toxicology
- Peptides
- ADME
- Antibodies
- Fill-finish
23 more
- Bioanalysis
- In vivo
- Analytical development
- Hit-to-lead
- ADME/PK
- Early biology
- In vitro pharmacology
- In vivo pharmacology
- Bioanalytical method development
- Custom assay development
- Potency testing
- Analytical validation
- Preformulation assessment
- Acute toxicity
- Subchronic toxicity
- Chronic toxicity
- Reproductive toxicity
- Developmental toxicity (DART)
- Hit-to-lead chemistry
- Early biology studies
- Developmental toxicity
- Safety pharmacology
- Genotoxicity
- Scale and capacity
- Over 100 vetted CDMOs and CROs in the network
- 80+ INDs filed to date
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
- Peptide
- Oligonucleotide
5 more
- mRNA
- Viral vector
- Cell therapy
- Vaccine
- Biosimilar
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: toxicology studies
GMPSelf-reported
Scope: drug product manufacturing and vetted manufacturing partners
Industries served
- Biotech
- Pharmaceutical
- Academic
- Industry
Details
- Type
- CRDMO
- Founded
- 1972
- Address
- 600 E Crescent Ave, Upper Saddle River, NJ 07458, United States
- Serves
- North America, Europe, Asia, global
- Phone
- (201) 995-0070
Public records
- Biocom California CRO directory
- clinical trials, Custom Chemistry, Drug Product, Preclinical Research, process development source